Targeting Neurofibromin 1 Deficiency by MEK inhibition in Tubo-ovarian High-Grade Serous Carcinoma
Rui Yang, Isabelle Nechala, James Key, Pooja Praveen Kumar et autres
0 citationsSSRN Electronic Journal
Helen Steed
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
209Publications signalées
4021Citations signalées
0Affiliations récentes
Domaines associés
Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer TreatmentsPARP inhibition in cancer therapyVirus-based gene therapy researchUterine Myomas and Treatments
Publications récentes
Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Nicola S. Meagher, Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon et autres
0 citations
Les avancées dans le traitement du cancer nécessitent des changements de toute urgence dans les effectifs en oncologie
Omar Abdel‐Rahman, Hyejee Ohm, Angela W. Chan, Shaun Loewen et autres
0 citationsCanadian Medical Association Journal
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Zhuxuan Fu, Lauren Borho, Sarah E. Taylor, Linda E Kelemen et autres
3 citationsGynecologic Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.